Abstract
TM9SF1 is a member of the TM9SF (Transmembrane 9 Superfamily Member) family, which usually has a long N-terminal extracellular region and nine transmembrane domains. TM9SF1’s biological function and mechanisms in inflammation are yet unknown. Tm9sf1 was shown to be upregulated in the lung tissues of mice suffering from LPS-induced acute lung injury (ALI). Tm9sf1 knockout mice were studied, and it was shown that Tm9sf1 knockout significantly alleviated LPS-induced ALI, as evidenced by higher survival rate, improved pulmonary vascular permeability, decreased inflammatory cell infiltration, and downregulated inflammatory cytokines. TM9SF1 was also demonstrated to be a negative regulator of autophagy in the LPS-induced ALI model in vitro and in vivo. The autophagy inhibitor 3-MA could counteract the beneficial effects of Tm9sf1 knockout on ALI. Therefore, we discover for the first time the role and mechanism of TM9SF1 in LPS-induced ALI and establish a relationship between TM9SF1 regulated autophagy and ALI progression, which may provide novel targets for the treatment of ALI.
Keywords: TM9SF1, ALI, Autophagy, Inflammation
TM9SF1; ALI, Autophagy; Inflammation.
1. Introduction
Acute lung injury (ALI), an acute inflammatory lung disease with high incidence and mortality, is characterized by a severe inflammatory response, increased alveolar-capillary permeability, and acute respiratory failure [1, 2]. Various factors could induce ALI, such as infection, trauma, and hemorrhagic shock [3]. However, due to the complex and largely unexplored molecular pathogenesis of ALI, no effective therapeutic drugs are currently available in clinical practice [4]. The main therapeutic strategies for ALI are to treat the primary disease while controlling the systemic inflammatory response. Therefore, identifying key molecules and mechanisms that respond to the severe symptoms of ALI and identifying novel effective therapeutic targets is critical.
Autophagy is a biological process that packages invading microbes, damaged organelles, and other cytoplasmic contents into double-membrane vesicles called autophagosomes for degradation [5]. Autophagy has been linked to the progression of ALI, according to research [6, 7]. Lipopolysaccharide (LPS) stimulation could induce autophagy in lung epithelial cells and pulmonary endothelial cells [8]. It is generally believed that autophagy has a protective role in the initiation and development of ALI [9]. When confronted with LPS, Atg4b deficient mice developed more severe lung injury by impairing ATF3 activity [10]. The autophagy inhibitor 3-MA inhibited the pro-autophagy and anti-inflammatory effects of glycyrrhizic acid in LPS-induced ALI [11]. BML-111, a lipoxin A4 receptor agonist, could reduce the levels of proinflammatory cytokines, inhibit apoptosis, and ameliorate LPS-induced ALI by stimulating autophagy [12]. However, some studies found that inhibiting autophagy with 3-MA or Atg5 knockdown ameliorated the symptoms and mortality associated with H5N1 infection [13]. These studies suggest that the protective or harmful roles of autophagy in ALI may be conditional, such as different induced ALI factors or cell types used in the studies.
Transmembrane 9 superfamily proteins (TM9SF) family, also known as nonaspanins, is a member of proteins characterized by a large non-cytoplasmic region and 9 transmembrane domains [14, 15]. In mammals, four members (TM9SF1-4) have been identified [15]. However, the biological functions of the TM9SF family remain unexplored. Only a few studies reported that their expression might be associated with the onset and progression of tumors [16, 17, 18, 19]. Both TM9SF1 and TM9SF4 have been shown to promote autophagy [20, 21]. The functional roles and underlying mechanism of the TM9SF family in inflammation are poorly understood. Tm9sf1-4 were all upregulated in the lung tissues of LPS-induced ALI mice. Tm9sf1 knockout (Tm9sf1−/−) mice had significantly alleviated ALI symptoms, including improved survival rate, decreased pulmonary vascular permeability, alleviative inflammatory cell infiltration, and downregulated inflammatory cytokines. We further found that TM9SF1 negatively regulated autophagy in the LPS-induced ALI model in vitro and in vivo. The autophagy inhibitor 3-MA was able to remove the protective role of Tm9sf1 knockout in ALI mice. This study may provide novel targets for ALI treatment.
2. Materials and methods
2.1. Cell lines and ALI cell model
Human lung epithelial adenocarcinoma cells A549 were obtained from the American Type Culture Collection (ATCC) and cultured in DMEM medium (12100-046; Gibco, USA) supplemented with 10% fetal bovine serum (900-108; Gemini, USA). For in vitro ALI model, the cells were treated with 10 μg/mL lipopolysaccharide (LPS; L2630, Sigma, USA) for 24 h.
2.2. Animals
Eight-week-old wild-type and Tm9sf1−/− C57BL/6 male mice (Shanghai Model Organisms Center, Inc., China) were used to establish the ALI mice model. All experimental procedures and protocols were approved by the Hubei University of Arts and Science Animal Ethics Committee, China. To identify the genotyping, we isolated DNA from the tail of mice and subjected them to PCR using the following primers: m-Tm9sf1JCRNA-F 5’-CTTGGCTCAGGAGAAGAGCC-3’ and m-Tm9sf1JCRNA-R 5’-AGCAGGATGGCGAAGACAAA-3’. RT-PCR was applied to examine the mRNA level of T Tm9sf1 in Tm9sf1−/− and wild-type mice. The primers used were as follows: m-Tm9sf1-F 5’-CCTTTGATGCACCTTGTCGC-3’ and m-Tm9sf1-F 5’-CCCCAGACTGTGGCAAAGAT-3’. m-Gapdh-F Primer: 5’-CCTCGTCCCGTAGACAAAATGGT-3’; m-Gapdh-R: 5’-TTGAGGTCAATGAAGGGGTCGT-3’ served as an internal control.
2.3. ALI mice model
The ALI mice model was established via intraperitoneal (i.p.) injection of 5 mg/kg of LPS (L2630, Sigma) dissolved in PBS. The Wt mice were randomly assigned to 2 groups, while the Tm9sf1−/− mice were assigned to 3 groups, with 8 mice in each group. The different groups were treated as follows: (1) Wt-Control: 100 μL of PBS; (2) Tm9sf1−/−-Control: 100 μL of PBS; (3) Wt-LPS: LPS dissolved in 100 μL of PBS; (4) Tm9sf1−/−-LPS: LPS dissolved in 100 μL of PBS; (4) Tm9sf1−/−-LPS+3-MA: 15 mg/kg 3-MA (S1049, Selleck, USA) dissolved in 50 μL of PBS, i.p. injected 1 h before LPS injection (dissolved in 50 μL of PBS) to inhibit autophagy. After LPS treatment for 24 h, the lung tissues and blood were collected for further experiments.
2.4. Histological analysis
The lung tissues were collected at 24 h after ALI induction. The tissues were fixed in 4% formalin overnight, embedded in paraffin, and sliced into 4-μm sections. The tissue sections were stained with hematoxylin and eosin (H&E) and subjected to histopathological evaluation using a light microscope (DSX100, Olympus, Japan). A semiquantitative injury scoring system was employed to evaluate lung injury. The scoring system involved 4 indicators: congestion, edema, inflammation, and hemorrhage [22]. Injury scoring grades ranged from 0 to 4: 0, normal; 1, damage of 0–25%; 2, damage of 25–50%; 3, damage of 50–75%; 4, damage of 75–100%. Four random visual fields were selected for each section.
2.5. Lung W/D weight measurement
The lung tissues were collected at 24 h after ALI induction. The tissues were wiped with a filter paper to remove the blood on the surface, and the wet weight (W) was determined. Then, the lung tissues were incubated at 60 °C for 48 h in an oven, after which the dry weight (D) was determined. Finally, the wet/dry (W/D) ratio was calculated.
2.6. Cell counts and protein quantitation in the bronchoalveolar lavage fluid (BALF)
The mice were anesthetized via i.p. injection with pentobarbitone (50 mg/kg) at 24 h after ALI induction. Then, the bronchoalveolar lavage fluid was analyzed by intratracheal injection with 1 mL of PBS, followed by gentle aspiration, pooling, and re-aspiration. After centrifugation, the cell pellet of the lavage fluid was resuspended in 100 μL of PBS, followed by cell counting. The protein concentration in the supernatant was determined by using a BCA quantitative kit (G2026; Servicebio, China).
2.7. Enzyme-linked immunosorbent assay (ELISA) and MPO activity
The protein levels of Mcp-1 (E4834, Bio Vision, CA), Il-1β (MLB00C Systems, Emeryville, CA), Tnf-α (K1051, Bio Vision) in the serum and lung homogenates were determined by using an ELISA kit. The MPO activity was detected by using an MPO Kit according to the manufacturer’s instructions (#A044; Nanjing Jiancheng Bioengineering Institute, China).
2.8. Immunohistochemistry (IHC) assay
The paraffin-embedded tissue sections were incubated at 65 °C for 2 h and then deparaffinized. For IHC staining, the endogenous peroxidase activity was blocked with 3% hydrogen peroxide at room temperature for 15 min. The slides were incubated with a primary antibody anti-Lc3 (12741, Cell Signaling, USA) at 4 °C overnight, followed by washing and incubating with an HRP-conjugated secondary antibody (GB23301, Servicebio) at room temperature for 5 min. The slides were then counterstained with hematoxylin.
2.9. RNA extraction and RT-PCR
Total RNA was extracted by TRIzol (269212, Ambion, USA). First-strand cDNAs were synthesized using the iScript cDNA Synthesis Kit (1708891, BIO-RAD, USA) according to the manufacturer’s instructions. The gene primer sequences and the internal controls used are listed in Table 1 qRT-PCR was performed on the ABI7500 system using the iTaq Universal SYBR Green Supermix (1725124, BIO-RAD) under the following conditions: 95 °C for 5 min; 40 cycles at 95 °C for 10 s; and 60 °C for 20 s. The 2−ΔΔCt method [23] was adopted for the calculation of the relative gene expression. Semi-RT-PCR was also conducted under the following conditions: 95 °C for 5 min; 30 cycles at 95 °C for 20 s; 60 °C for 20 s; 72 °C for 20 s; and 72 °C for 5 min.
Table 1.
RT-PCR primer sequences.
| Primer name | Sequence (5'-3') | Organism |
|---|---|---|
| GAPDH-F | GGAGCGAGATCCCTCCAAAAT | human |
| GAPDH-R | GGCTGTTGTCATACTTCTCATGG | human |
| TNF-α-F | GACAGATGTGGGGTGTGAGAA | human |
| TNF-α-R | TCTGTGTGCCAGACACCCTA | human |
| TM9SF1–F | GCACCCTGTCGCACCAAG | human |
| TM9SF1-R | GACAAAGAAGAGGATGCCGTAC | human |
| Gapdh-F | ATGACTCTACCCACGGCAAG | mouse |
| Gapdh-R | TACTCAGCACCAGCATCACC | mouse |
| Tm9sf1-F | GCCTCTGAAACTGGACACG | mouse |
| Tm9sf1-R | CCTCTTCCTCCTGGC TCTCT | mouse |
| Tm9sf 2-F | ACTGTGCTGGTCTCCTTGCT | mouse |
| Tm9sf 2-R | CAGGGTG CTGGGTTAGGTTA | mouse |
| Tm9sf 3-F | CTCTGCCTTGGAACATCACA | mouse |
| Tm9sf 3-R | AGCGTCAGCTTCCTTCACAC | mouse |
| Tm9sf 4-F | AGAGCGATACAAGGG TGAGAA | mouse |
| Tm9sf 4-R | CACTTCAGAGATGGGTGTGG | mouse |
2.10. Autophagy flux assays
A549 cells were infected with an adenovirus-expressing tandem mRFP-GFP-LC3 fusion protein (HANBIO, Shanghai, China). After 24 h of infection, the cells were transfected with si-TM9SF1 or si-Scramble (si-TM9SF1: 5’-GGUUACGACCUGACGAGUUTT-3’; si-Scramble: 5'-UUCUCCGAACGUGUCACGUTT-3' (Gene Pharma Company, Suzhou, China) for 24 h. Then, the cells were incubated with 10 ug/mL of LPS for 24 h and fixed with 4% paraformaldehyde. The microphotographs of RFP-GFP-LC3 fluorescence were acquired with a confocal laser scanning microscope (Leica SP8, Germany). Autophagic flux was assessed by counting the number of yellow dots and red dots in each cell (20 cells were scored/each group).
2.11. Western blotting
The western blotting assay was performed as described previously [24]. The primary antibodies used were as follows: anti-Gapdh (AB-P-R 001, GoodHere, China), anti-Tm9sf1 (PA5-84406, Invitrogen, USA), anti-p62 (A7758, ABclonal, China), and anti-Lc3 (12741, Cell Signalling, USA).
2.12. Statistical analysis
Statistical analysis was conducted using the IBM SPSS Statistics 25.0. The student’s t-test was applied to compare the means between the two groups. One-way analysis of variance (ANOVA) and two-way ANOVA were used for comparison between more than two groups. Unless otherwise mentioned, the values were expressed as means ±SDs. Kaplan–Meier survival analysis was applied to evaluate the survival rate in different groups. P < 0.05 was considered to indicate statistical significance. The sample size was calculated using the PASS software by power analysis (1-β = 0.80). GraphPad Prism9 software was conducted for Graph drawing.
3. Results
3.1. Tm9sf1 is upregulated in the lung tissues of ALI mice
We utilized LPS to induce ALI models in mice to evaluate the expression of TM9SF members (TM9SF1-4). Tm9sf1 was the most significantly up-regulated member among these four members in the lung tissues of ALI mice (Figure 1A). The protein levels of Tm9sf1 were significantly increased, especially when the mice with LPS were exposed for 24 h (Figures. 1B-C). IHC and IF staining verified the increased Tm9sf1 protein expression (Figure. 1D-E). Tm9sf1 may play important role in the development of ALI induced by LPS, according to our findings.
Figure 1.
Tm9sf1 expression in the lung tissues of an ALI mice model. (A) The mRNA expression of Tm9sf1, Tm9sf2, Tm9sf3, and Tm9sf4 in the lung tissues of the LPS-induced ALI mice model. The mice were challenged with LPS for 24 h. (B) Western blotting analysis of the Tm9sf1 protein levels in the lung tissues of LPS-induced ALI mice model. The mice were challenged with LPS for the indicated time points. (C) Quantification of the Tm9sf1 levels relative to that of Gapdh in the lung tissues treated as in (B). (D-E) The Tm9sf1 protein levels in the lung tissues of ALI mice were determined by (D) IHC and (E) IF staining. The mice were challenged with LPS for 24 h. ∗P < 0.05, ∗∗P < 0.01. n = 3 in each group.
3.2. Tm9sf1 knockout enhanced autophagy in ALI mice model
To explore the functional roles of TM9SF1 in ALI, we used the CRISPR/Cas9 strategy to generate Tm9sf1 knockout mice (Tm9sf1−/−) (Figure 2A). RT-PCR showed that Tm9sf1 expression was completely abolished in Tm9sf1 −/− mice (Figure 2A). The previous study reported that TM9SF1 could promote autophagy in HeLa cells [20]. Since autophagy plays important role in the initiation and development of ALI [25], we wonder whether Tm9sf1 knockout affects autophagy in the ALI mice model. Surprisingly, the autophagosome marker Lc3-II was up-regulated in the lung tissues of Tm9sf1−/− mice compared to control mice. Tm9sf1 knockout decreased p62, an endogenous autophagy substrate degraded during the autophagic process (Figure 2B-D). These results suggest that Tm9sf1 knockout enhances autophagy in LPS-induced lung injury.
Figure 2.
Tm9sf1 knockout promoted autophagy in the ALI mice model. (A) Generation of Tm9sf1−/− mice. The left side depicts the Tm9sf1-knockout strategy by CRISPR/Cas9. The middle side: Genomic DNA was extracted and analyzed by PCR. The mRNA levels of Tm9sf1 in Tm9sf 1−/− and Wt mice are depicted on the right side. (B) Western blotting of Lc3-II and p62 protein levels in the lung tissues from Wt-Control, Tm9sf 1−/−-Control, Wt-LPS, and Tm9sf 1−/−-LPS mice. (C-D) Densitometric analysis of Lc3-II and p62 bands relative to that of Gapdh in (B). ∗P < 0.05, ∗∗P < 0.01. n = 3 in each group.
3.3. TM9SF1 knockdown enhanced autophagy in vitro
We next investigated the regulation of TM9SF1 on autophagy in vitro. TNF-α was increased when lung epithelial adenocarcinoma cells A549 were treated with LPS for 24 h, indicating that A549 can be used to establish the in vitro model of ALI (Figure 3A-B). We further infected the cells with adenovirus expressing tandem mRFP-GFP-LC3 fusion protein, which is used to identify autophagosomes (RFP positive/GFP positive) and autolysosomes (GFP-negative/RFP-positive). GFP fluorescence is quenched in cellular compartments with low pH when autophagosomes fuse with lysosomes [26]. TM9SF1 knockdown increased the number of autolysosomes and autophagosomes in A549 cells treated with LPS (Figure 3C-F), suggesting that TM9SF1 knockdown promotes autophagy in vitro.
Figure 3.
TM9SF1 knockdown promoted autophagy in A549 cells. (A) Semi-RT-PCR analysis of the TNF-α mRNA levels in A549 cells challenged with LPS for the indicated time points. (B) qRT-PCR analysis of the TNF-α mRNA levels in A549 cells challenged with LPS for the indicated time points. (C) qRT-PCR analysis of TM9SF1-knockdown efficiency in A549 cells transfected with si-TM9SF1 or si-Scramble. (D) TM9SF1-knockdown A549 cells and control cells were infected with adenovirus-expressing tandem RFP-GFP-LC3 and treated with LPS for 24 h. RFP-GFP-LC3B puncta distribution was observed by confocal microscopy. Representative confocal microscopy images are shown. (E–F) Fluorescence intensity quantitation (E) and dot quantitation of autophagosomes and autolysosomes (F) in cells treated as in (D). Scale bar = 50 μm. ∗P < 0.05, ∗∗P < 0.01. n = 20 cells in each group.
3.4. Tm9sf1 knockout improved lung inflammatory injury in ALI mice depending on autophagy
The effects of Tm9sf1 knockout on ALI progression were also discovered. The pulmonary epithelium of Tm9sf1−/− mice developed normally compared with wild-type mice (Figure 4B). LPS could induce acute lung injuries, such as alveolar collapse, stroma haemorrhagia, pulmonary edema, and inflammatory cell infiltration [8]. These symptoms, however, were alleviated when Tm9sf1 was knocked out (Figure 4B-C). When confronted with LPS, Tm9sf1−/− mice had a higher survival rate (Figure 4A). Then we detected whether Tm9sf1 regulated autophagy was involved in its effect on ALI. 3-MA, an inhibitor for phosphatidylinositol 3-kinases, could abolish the beneficial effects of Tm9sf1 knockout on ALI (Figure 4A-C). These results demonstrated that Tm9sf1 knockout improved lung injury in ALI mice depending on autophagy.
Figure 4.
Tm9sf1 knockout improved the survival rate and ameliorated lung injury in an ALI mice model. Wild type and Tm9sf1−/− mice were challenged with LPS or PBS combined with or without 3-MA for 24 h. (A) Kaplan–Meier survival analysis of the mice in different groups. (B) Representative H&E staining of the lung tissues in different groups. (C) The lung injury scores in (B). ∗P < 0.05, ∗∗P < 0.01. n = 8 in each group.
3.5. Tm9sf1 knockout decreased pulmonary epithelial barrier permeability and inflammatory cell infiltration in ALI mice
LPS may cause pulmonary edema and increased protein levels in BALF by increasing pulmonary epithelial barrier permeability [27]. In LPS-treated mice, the lung wet/dry ratio and protein concentration in BALF were significantly increased (Figure 5A-B). Myeloperoxidase (MPO), a neutrophil marker, indicates the degree of inflammatory cell infiltration and the progression of lung injury in ALI [28]. In the lung tissues of LPS-treated mice, the total cell count, percentage of neutrophils, and MPO activity were all higher than in wild-type mice (Figures. 5C-E). Tm9sf1 knockout could attenuate the increased wet/dry ratio, BALF’s protein levels, total cell count, percentage of neutrophils, and MPO activity induced by LPS (Figures. 5A-E). Moreover, administration of 3-MA inhibited the protective effects induced by Tm9sf1 knockout (Figures. 5A-E).
Figure 5.
Tm9sf1 knockout decreased inflammatory cell infiltration in ALI mice. (A) Wet lung/dry lung weight ratio in Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (B) Protein concentrations of BALF in Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (C) Total cells of BALF in Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (D) Neutrophil percentage of BALF in Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (E) Myeloperoxidase (MPO) activity in the supernatant of lung homogenate from Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. ∗P < 0.05, ∗∗P < 0.01. n = 8 in each group.
3.6. Tm9sf1 knockout decreased inflammatory cytokine levels in the serum and pulmonary tissues of ALI mice
MCP-1, IL-1β, and TNF-α are inflammatory cytokines that play important roles in the progression of ALI [29]. The levels of Il-1β, Tnf-α, and Mcp-1were evaluated in the serum and lung homogenate of mice from the Wt-Control, Tm9sf1−/− Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. The results showed that Il-1β, Tnf-α, and Mcp-1 levels were decreased in the Tm9sf1−/−-LPS group compared to the Wt-LPS group. 3-MA reversed the anti-inflammatory effects induced by Tm9sf1 knockout (Figures. 6A-B).
Figure 6.
Tm9sf1 knockout suppressed inflammation in LPS-induced an ALI mice model. (A) Il-1β, Tnf-α, and Mcp-1 levels in the serum from Wt-Control, Tm9sf1−/− Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (B) Il-1β, Tnf-α, and Mcp-1 levels in the supernatant of lung homogenate from Wt-Control, Tm9sf1−/− Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. ∗P < 0.05. n = 8 in each group.
3.7. 3-MA reversed the autophagy enhancement in Tm9sf1 knockout ALI mice
Finally, we analyzed the change of autophagy in the lung tissues from the Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. Lc3-II protein levels were increased in the Tm9sf1−/−-LPS group, while p62 protein levels were decreased in the Wt-LPS group. 3-MA could suppress the enhanced autophagy induced by Tm9sf1−/− knockout (Fig. 7A-C).
Figure 7.
3-MA inhibited the enhanced autophagy induced by Tm9sf1 knockout. (A) Lc3-II and p62 protein levels in the lung tissues from Wt-Control, Tm9sf1−/−-Control, Wt-LPS, Tm9sf1−/−-LPS, and Tm9sf1−/−-LPS+3-MA groups. (B, C) Densitometric analysis of Lc3-II and p62 bands in (A). ∗P < 0.05, ∗∗P < 0.01. n = 8 in each group.
4. Discussion
The TM9SF family (TM9SF1-4 in mammals), a class of evolutionarily conserved proteins, are widely expressed in various tissues [30]. The biological function of the TM9SF family is currently unknown. In this study, we found that all four TM9SF members were upregulated in the lung tissues of LPS-induced ALI mice models, suggesting potential roles of the TM9SF family in the progression of inflammatory diseases. We further established Tm9sf1−/− knockout mice and found that Tm9sf1 knockout significantly improved LPS-induced ALI, as evidenced by improved survival rate, decreased pulmonary vascular permeability, inflammatory cell infiltration, and downregulated inflammatory cytokines. Therefore, TM9SF1 may be an unfavorable factor in LPS-induced ALI progression.
ALI progression evolves with a series of genetic and pathway alterations. Autophagy has been shown to play an important role in this process among these mechanisms [31]. A previous study reported that TM9SF1 colocalized with the autophagosome marker LC3 and enhanced autophagy in HeLa cells [20]. TM9SF1 is an autophagy suppressor in LPS-induced ALI, as evidenced by the accumulation of GFP-RFP-LC3 in the TM9SF1 knockdown A549 cells, and the upregulation of LC3-II and decreased p62 protein levels in Tm9sf1 knockout mice. A possible explanation for these contradictory results might be the two studies’ differing cell or tissue contexts. TM9SF1 was also detected in the mitochondria of A549 cells (data not shown), but not in HeLa cells. The molecular mechanism of how TM9SF1 modulates autophagy requires further study.
The relationship between autophagy and ALI is complicated since it has both protective and inhibitory functions. The autophagy inhibitor 3-MA might negate the protective effects of genipin in ALI [32]. 3-MA could also abolish glycyrrhizic acid’s pro-autophagy and anti-inflammatory effects on LPS-induced ALI [11]. However, another study reported that the autophagy inhibitor 3-MA protects against endothelial cell barrier dysfunction in LPS-induced ALI [33], and that macrophage-specific Atg5 knockout mice exhibited attenuated symptoms in Ischemia-reperfusion (IR)-induced ALI [34]. Silencing autophagy-related genes (siATG5 or siATG7) or the autophagosome-lysosome fusion inhibitor chloroquine markedly reduced pulmonary microvascular endothelial cell permeability and attenuated LPS-induced ALI [13, 27, 35]. The reason for these different findings is currently unclear. We speculate that targeting different molecules or genes in various types of pulmonary cells may affect autophagy via different molecular mechanisms, thus having distinct roles in the progression of ALI. For example, RAB26 interacted with ATG16L1 and protected endothelial cell permeability, which is dependent on autophagic degradation of phosphorylated SRC [36]. H2S (hydrogen sulfide) treatment attenuated ventilator-induced ALI by inhibiting autophagy via the ROS/AMPK/mTOR pathway [37]. In brief, our study showed that Tm9sf1 knockout-induced autophagy protects against LPS-induced ALI. However, the specific mechanism through which Tm9sf1 knockout improves ALI by regulating autophagy remains unclear and requires additional investigation.
In the present study, we observed that TM9SF1 was upregulated in LPS-exposed mouse lung tissues. Tm9sf1 knockout could significantly improve LPS-induced ALI. Autophagy may play a crucial role in the development of LPS-induced inflammatory lung injury. TM9SF1 knockout attenuates LPS-induced ALI by activating autophagy. However, the underlying mechanism by which Tm9sf1 knockout improves ALI via regulating autophagy remains unclear and needs to be further studied. In summary, the present study suggests that TM9SF1 may be a new therapeutic target for ALI treatment.
Declarations
Author contribution statement
Juan Xiao, Chun Mao: Conceived and designed the experiments; Wrote the paper.
Xiaofang Shen, Huabo Chen: Performed the experiments; Wrote the paper.
Lu Ding: Performed the experiments; Analyzed and interpreted the data; Wrote the paper.
Ke Wang: Analyzed and interpreted the data; Wrote the paper.
Lihong Zhai: Conceived and designed the experiments; Performed the experiments; Wrote the paper.
Funding statement
Juan Xiao was supported by the scientific and technological research projects of Hubei Education Department [D20202602], Subject fund of Hubei University of Arts and Science [2021kptd02].
Data availability statement
Data included in article/supp. material/referenced in article.
Declaration of interest’s statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
Acknowledgements
The authors would like to thank all the reviewers who participated in the review and MJEditor (www.mjeditor.com) for its linguistic assistance during the preparation of this manuscript.
Contributor Information
Lihong Zhai, Email: zlh_0302@126.com.
Chun Mao, Email: 50001@hbuas.edu.cn.
References
- 1.Khemani R.G., et al. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. Lancet Respir. Med. 2019;7(2):115–128. doi: 10.1016/S2213-2600(18)30344-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mowery N.T., Terzian W.T.H., Nelson A.C. Acute lung injury. Curr. Probl. Surg. 2020;57(5) doi: 10.1016/j.cpsurg.2020.100777. [DOI] [PubMed] [Google Scholar]
- 3.Li J., et al. The reaction pathway of miR-30c-5p activates lipopolysaccharide promoting the course of traumatic and hemorrhagic shock acute lung injury. BioMed Res. Int. 2022;2022 doi: 10.1155/2022/3330552. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 4.Mokra D. Acute lung injury - from pathophysiology to treatment. Physiol. Res. 2020;69(Suppl 3):S353–S366. doi: 10.33549/physiolres.934602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Deretic V. Autophagy in inflammation, infection, and immunometabolism. Immunity. 2021;54(3):437–453. doi: 10.1016/j.immuni.2021.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhao H., et al. Autophagy activation improves lung injury and inflammation in sepsis. Inflammation. 2019;42(2):426–439. doi: 10.1007/s10753-018-00952-5. [DOI] [PubMed] [Google Scholar]
- 7.Vishnupriya S., et al. Autophagy markers as mediators of lung injury-implication for therapeutic intervention. Life Sci. 2020;260 doi: 10.1016/j.lfs.2020.118308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhang D., et al. Autophagy maintains the integrity of endothelial barrier in LPS-induced lung injury. J. Cell. Physiol. 2018;233(1):688–698. doi: 10.1002/jcp.25928. [DOI] [PubMed] [Google Scholar]
- 9.Qin L., et al. Mechanistic target of rapamycin-mediated autophagy is involved in the alleviation of lipopolysaccharide-induced acute lung injury in rats. Int. Immunopharm. 2020;78 doi: 10.1016/j.intimp.2019.105790. [DOI] [PubMed] [Google Scholar]
- 10.Aguirre A., et al. Defective autophagy impairs ATF3 activity and worsens lung injury during endotoxemia. J. Mol. Med. (Berl.) 2014;92(6):665–676. doi: 10.1007/s00109-014-1132-7. [DOI] [PubMed] [Google Scholar]
- 11.Qu L., et al. Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. Am. J. Transl. Res. 2019;11(4):2042–2055. [PMC free article] [PubMed] [Google Scholar]
- 12.Liu H., et al. Lipoxin A4 receptor agonist BML-111 induces autophagy in alveolar macrophages and protects from acute lung injury by activating MAPK signaling. Respir. Res. 2018;19(1):243. doi: 10.1186/s12931-018-0937-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhang R.H., et al. Autophagy is involved in the acute lung injury induced by H9N2 influenza virus. Int. Immunopharm. 2019;74 doi: 10.1016/j.intimp.2019.105737. [DOI] [PubMed] [Google Scholar]
- 14.Froquet R., et al. Control of cellular physiology by TM9 proteins in yeast and Dictyostelium. J. Biol. Chem. 2008;283(11):6764–6772. doi: 10.1074/jbc.M704484200. [DOI] [PubMed] [Google Scholar]
- 15.Pruvot B., et al. Comparative analysis of nonaspanin protein sequences and expression studies in zebrafish. Immunogenetics. 2010;62(10):681–699. doi: 10.1007/s00251-010-0472-x. [DOI] [PubMed] [Google Scholar]
- 16.Clark C.R., et al. Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci. Rep. 2018;8(1) doi: 10.1038/s41598-018-33527-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Oo H.Z., et al. Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor. Pathobiology. 2014;81(3):138–148. doi: 10.1159/000357821. [DOI] [PubMed] [Google Scholar]
- 18.Shen L., et al. miR-1193 suppresses the proliferation and invasion of human T-cell leukemia cells through directly targeting the transmembrane 9 superfamily 3 (TM9SF3) Oncol. Res. 2017;25(9):1643–1651. doi: 10.3727/096504017X14908284471361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Paolillo R., et al. Human TM9SF4 is a new gene down-regulated by hypoxia and involved in cell adhesion of leukemic cells. PLoS One. 2015;10(5):e0126968. doi: 10.1371/journal.pone.0126968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.He P., et al. High-throughput functional screening for autophagy-related genes and identification of TM9SF1 as an autophagosome-inducing gene. Autophagy. 2009;5(1):52–60. doi: 10.4161/auto.5.1.7247. [DOI] [PubMed] [Google Scholar]
- 21.Sun L., et al. TM9SF4 is a novel factor promoting autophagic flux under amino acid starvation. Cell Death Differ. 2018;25(2):368–379. doi: 10.1038/cdd.2017.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Fan K., et al. Lipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy. Front. Immunol. 2018;9:1464. doi: 10.3389/fimmu.2018.01464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 24.Xiao J., et al. Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis. J. Neuroinflammation. 2015;12(1):117. doi: 10.1186/s12974-015-0338-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wang K., et al. Protective features of autophagy in pulmonary infection and inflammatory diseases. Cells. 2019;8(2) doi: 10.3390/cells8020123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yang H., et al. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance. Autophagy. 2019;15(9):1539–1557. doi: 10.1080/15548627.2019.1586248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Guo L., et al. Autophagy inhibition protects from alveolar barrier dysfunction in LPS-induced ALI mice by targeting alveolar epithelial cells. Respir. Physiol. Neurobiol. 2021;283 doi: 10.1016/j.resp.2020.103532. [DOI] [PubMed] [Google Scholar]
- 28.Ren R., et al. Verdiperstat attenuates acute lung injury by modulating MPO/mu-calpain/beta-catenin signaling. Eur. J. Pharmacol. 2022;924 doi: 10.1016/j.ejphar.2022.174940. [DOI] [PubMed] [Google Scholar]
- 29.Li W., et al. Nobiletin-ameliorated lipopolysaccharide-induced inflammation in acute lung injury by suppression of NF-kappaB pathway in vivo and vitro. Inflammation. 2018;41(3):996–1007. doi: 10.1007/s10753-018-0753-3. [DOI] [PubMed] [Google Scholar]
- 30.Chluba-de Tapia J., et al. Cloning of a human multispanning membrane protein cDNA: evidence for a new protein family. Gene. 1997;197(1-2):195–204. doi: 10.1016/s0378-1119(97)00263-1. [DOI] [PubMed] [Google Scholar]
- 31.Pehote G., Vij N. Autophagy augmentation to alleviate immune response dysfunction, and resolve respiratory and COVID-19 exacerbations. Cells. 2020;9(9) doi: 10.3390/cells9091952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhang Z., et al. Genipin protects rats against lipopolysaccharide-induced acute lung injury by reinforcing autophagy. Int. Immunopharm. 2019;72:21–30. doi: 10.1016/j.intimp.2019.03.052. [DOI] [PubMed] [Google Scholar]
- 33.Slavin S.A., et al. Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2018;314(3):L388–L396. doi: 10.1152/ajplung.00555.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hu R., et al. Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis. Cell Death Dis. 2014;5:e1330. doi: 10.1038/cddis.2014.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Shadab M., et al. Autophagy protein ATG7 is a critical regulator of endothelial cell inflammation and permeability. Sci. Rep. 2020;10(1) doi: 10.1038/s41598-020-70126-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dong W., et al. RAB26-dependent autophagy protects adherens junctional integrity in acute lung injury. Autophagy. 2018;14(10):1677–1692. doi: 10.1080/15548627.2018.1476811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang Y., et al. Hydrogen-rich saline ameliorated LPS-induced acute lung injury via autophagy inhibition through the ROS/AMPK/mTOR pathway in mice. Exp. Biol. Med. 2019;244(9):721–727. doi: 10.1177/1535370219847941. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data included in article/supp. material/referenced in article.







